Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Knee Surgery, Sports Traumatology, Arthroscopy

Open Access 01-06-2019 | KNEE

A brief introduction to health economics

Published in: Knee Surgery, Sports Traumatology, Arthroscopy | Issue 6/2019

Login to get access

Abstract

To convince policy-makers or funders of health care of the value of orthopaedic interventions, we need to consider value for money (cost-effectiveness), as well as clinical effectiveness. This article provides an introduction to health economics to set the scene for papers on the use of allografts in the knee.
Literature
1.
Barton GR, Sach TH, Jenkinson C, Avery AJ, Doherty M, Muir KR (2008) Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores? Health Qual Life Outc 6(no pagination):51CrossRef
2.
Brazier J, Roberts J, Deverill M (2002) The estimation of a preference-based measure of health from the SF-36. J Health Econ 21:271–292CrossRefPubMed
3.
4.
Claxton K, Martin S, Soares M, Rice N, Spackman E, Hinde S et al (2015) Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. Health Technol Assess 19:1–503CrossRefPubMedPubMedCentral
5.
Gerlier L, Lamotte M, Wille M, Kreuz PC, Vanlauwe J, Dubois D et al (2010) The cost utility of autologous chondrocytes implantation using ChondroCelect(R) in symptomatic knee cartilage lesions in Belgium. Pharmacoeconomics 28:1129–1146CrossRefPubMed
6.
Kirkley A, Griffin S, Whelan D (2007) The development and validation of a quality of life-measurement tool for patients with meniscal pathology: the Western Ontario Meniscal Evaluation Tool (WOMET). Clin J Sport Med 17:349–356CrossRefPubMed
7.
McConnell S, Kolopack P, Davis AM (2001) The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. Arthritis Rheum 45:453–461CrossRefPubMed
8.
Mistry H, Connock M, Pink J, Shyangdan D, Clar C, Royle P et al (2017) Autologous chondrocyte implantation in the knee: systematic review and economic evaluation. Health Technol Assess 21:1–294CrossRefPubMedPubMedCentral
9.
10.
Roos H, Lauren M, Adalberth T, Roos EM, Jonsson K, Lohmander LS (1998) Knee osteoarthritis after meniscectomy: prevalence of radiographic changes after twenty-one years, compared with matched controls. Arthritis Rheum 41:687–693CrossRefPubMed
11.
Wailoo A, Hernandez Alava M, Escobar Martinez A (2014) Modelling the relationship between the WOMAC Osteoarthritis Index and EQ-5D. Health Qual Life Outc 12:37CrossRef
12.
Xie F, Pullenayegum EM, Li SC, Hopkins R, Thumboo J, Lo NN (2010) Use of a disease-specific instrument in economic evaluations: mapping WOMAC onto the EQ-5D utility index. Value Health 13:873–878CrossRefPubMed
Metadata
Title
A brief introduction to health economics
Publication date
01-06-2019
Published in
Knee Surgery, Sports Traumatology, Arthroscopy / Issue 6/2019
Print ISSN: 0942-2056
Electronic ISSN: 1433-7347
DOI
https://doi.org/10.1007/s00167-019-05372-y